Total reward satisfaction profiles and work performance: A person-centered approach

by Chunling Li, Xueyun Duan, Xiangling Chu, Yong Qiu
Published 2023-03-01

Identification of nomogram associated with durable clinical benefit gene for advanced non-small cell lung cancer with sensitivity to responsive to immunotherapy

by Li Wang, Xiangling Chu, Xin Yu, Chunxia Su
Published 2024-04-01

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

by Jianing Chen, Jianing Chen, Yaokai Wen, Yaokai Wen, Xiangling Chu, Xiangling Chu, Yuzhi Liu, Yuzhi Liu, Chunxia Su, Chunxia Su
Published 2022-08-01

DNMT3A-mediated DNA methylation and transcription inhibition of FZD5 suppresses lung carcinogenesis

by Jiqiao Shen, Jinchen Su, Xiangling Chu, Xin Yu, Xiwen Gao
Published 2024-05-01

Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer

by Mengqing Xie, Xin Yu, Xiangling Chu, Huikang Xie, Juan Zhou, Jing Zhao, Chunxia Su
Published 2022-02-01

Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance

by Juan Zhou, Xiangling Chu, Jing Zhao, Mengqing Xie, Jing Wu, Xin Yu, Yujia Fang, Yazhou Li, Xiyan Li, Chunxia Su
Published 2023-07-01

A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations

by Li Wang, Yueran Wu, Zhixuan Ren, Xiangling Chu, Jianing Chen, Li Liu, Jing Zhao, Xin Yu, Mengqing Xie, Chunxia Su
Published 2024-06-01

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

by Juan Zhou, Jing Zhao, Qingzhu Jia, Qian Chu, Fei Zhou, Xiangling Chu, Wencheng Zhao, Shengxiang Ren, Caicun Zhou, Chunxia Su
Published 2021-03-01

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

by Juan Zhou, Chao Zhao, Jing Zhao, Qi Wang, Xiangling Chu, Jiayu Li, Fei Zhou, Shengxiang Ren, Xuefei Li, Chunxia Su, Caicun Zhou
Published 2019-04-01

PMS2 amplification contributes brain metastasis from lung cancer

by Jianing Chen, Congli Hu, Hainan Yang, Li Wang, Xiangling Chu, Xin Yu, Shiji Zhang, Xuefei Li, Chao Zhao, Lei Cheng, Weiping Hong, Da Liu, Lei Wen, Chunxia Su
Published 2024-05-01